NCT02787018View on ClinicalTrials.gov

Dexamethasone Compared With Dexmedetomidine as an Adjuvant to Ropivacaine for Supraclavicular Brachial Plexus Block

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Brachial Plexus Block
Interventions
DRUG

Ropivacaine and Normal saline

Supraclavicular brachial plexus block will be given with 0.5% ropivacaine with 1 ml normal saline

DRUG

Ropivacaine and Dexamethasone

Supraclavicular brachial plexus block will be given with 0.5% ropivacaine with 4mg (1ml) dexamethasone

DRUG

Ropivacaine and Dexmedetomidine

Supraclavicular brachial plexus block will be given with 0.5% ropivacaine with 50 mcg (1ml) dexmedetomidine

Trial Locations (1)

56700

B. P. Koirala Institute of Health Sciences, Dharān

All Listed Sponsors
lead

B.P. Koirala Institute of Health Sciences

OTHER

NCT02787018 - Dexamethasone Compared With Dexmedetomidine as an Adjuvant to Ropivacaine for Supraclavicular Brachial Plexus Block | Biotech Hunter | Biotech Hunter